Literature DB >> 22762244

Cyclical vomiting syndrome in children: a prospective study.

B R Drumm1, B Bourke, J Drummond, F McNicholas, S Quinn, A Broderick, S Taaffe, J Twomey, M Rowland.   

Abstract

BACKGROUND: Cyclical vomiting syndrome (CVS) is a disorder that affects all ages and is characterized by episodes of severe nausea and vomiting with symptom-free intervals between episodes. The incidence in children is 3.15/100 000 children per year. Our objective was to evaluate the natural history of CVS and examine factors that predict symptom resolution.
METHODS: Thirty newly diagnosed children (mean 9.15 years, SD 3.31 range 3.5-15.7) were enrolled. All children had a follow-up interview at 3 months, 27/30 at 6 months, and 22/30 at 9 months. KEY
RESULTS: Following diagnosis of CVS, only 5/22(22.7%) children had no further episodes of vomiting at 9 months, whereas 17/22 (77.3%) continued to vomit. In the year prior to diagnosis, 15/30 (50%) children were admitted to hospital. Of the 22 children with follow-up for 9 months, only one child required hospital admission. Children who continued to vomit had higher internalizing scores on CBCL compared with those who stopped vomiting (P = NS). The Pediatric Quality-of-Life Score suggested those who continued to vomit had a poorer quality of life at diagnosis compared with those who stopped vomiting (P < 0.05). CONCLUSIONS & INFERENCES: Making a positive diagnosis of CVS and providing families with information is very important in the management of CVS. Although 75% of children reported regular episodes of vomiting 9 months after diagnosis, there was a significant reduction in the frequency and severity of symptoms in addition to a marked reduction in the use of medical services.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22762244     DOI: 10.1111/j.1365-2982.2012.01960.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  5 in total

Review 1.  Pediatric migraine variants: a review of epidemiology, diagnosis, treatment, and outcome.

Authors:  Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2015-06       Impact factor: 5.081

2.  Anxiety and physiological responses to the Trier Social Stress Test for Children in adolescents with cyclic vomiting syndrome.

Authors:  Sally E Tarbell; Amanda Millar; Mark Laudenslager; Claire Palmer; John E Fortunato
Journal:  Auton Neurosci       Date:  2016-08-16       Impact factor: 3.145

3.  Yield and Costs of Evaluating Children With Cyclic Vomiting Syndrome.

Authors:  Chantal J Lucia-Casadonte; Kaitlin G Whaley; Ashish S Chogle
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-07       Impact factor: 2.839

4.  Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP).

Authors:  Sara Isoldi; Giovanni Di Nardo; Saverio Mallardo; Pasquale Parisi; Umberto Raucci; Renato Tambucci; Paolo Quitadamo; Silvia Salvatore; Enrico Felici; Fabio Cisarò; Licia Pensabene; Claudia Banzato; Caterina Strisciuglio; Claudio Romano; Patrizia Fusco; Francesca Rigotti; Naire Sansotta; Silvia Caimmi; Salvatore Savasta; Giovanna Zuin; Marina Di Stefano; Silvia Provera; Angelo Campanozzi; Paolo Rossi; Simona Gatti; Mara Corpino; Patrizia Alvisi; Stefano Martelossi; Agnese Suppiej; Paolo Gandullia; Alberto Verrotti; Gianluca Terrin; Caterina Pacenza; Fabiola Fornaroli; Donatella Comito; Stefano D'Arrigo; Pasquale Striano; Federico Raviglione; Marco Carotenuto; Alessandro Orsini; Vincenzo Belcastro; Giovanna Di Corcia; Vincenzo Raieli; Michela Ada Noris Ferilli; Claudia Ruscitto; Elisabetta Spadoni; Salvatore Grosso; Renato D'Alonzo; Amanda Papa; Piero Pavone; Mariaclaudia Meli; Mario Velardita; Martina Mainetti; Nicola Vanacore; Osvaldo Borrelli
Journal:  Ital J Pediatr       Date:  2022-08-30       Impact factor: 3.288

Review 5.  The childhood migraine syndrome.

Authors:  Ishaq Abu-Arafeh; Amy A Gelfand
Journal:  Nat Rev Neurol       Date:  2021-05-26       Impact factor: 42.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.